tirzepatide and colitis Acute Mesenteric Ischemia as a Severe Complication Associated With Tirzepatide: A Case Report Safety Alert GLP-1RAs for IBD | Docwire

However, patents validate novelty, not clinical efficacy

Obesity Research & Clinical Practice, 9(3), 301-304

The medication also increases glucagon-like peptide-1 (GLP-1) , a gut hormone that helps control blood sugar, slows gastric emptying, and decreases hunger signals to the brain

Gastrointestinal side effects, including constipation, nausea, and altered bowel habits, occur frequently with these medicines

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER The approval of a new higher dose will provide adult patients with an additional therapeutic option, offering the potential for greater weight loss, the agency stated